Antioxidants (Oct 2021)

NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin

  • Juan A. Parga,
  • Ana I. Rodriguez-Perez,
  • Maria Garcia-Garrote,
  • Jannette Rodriguez-Pallares,
  • Jose L. Labandeira-Garcia

DOI
https://doi.org/10.3390/antiox10111649
Journal volume & issue
Vol. 10, no. 11
p. 1649

Abstract

Read online

Reactive oxygen species (ROS) are signalling molecules used to regulate cellular metabolism and homeostasis. However, excessive ROS production causes oxidative stress, one of the main mechanisms associated with the origin and progression of neurodegenerative disorders such as Parkinson’s disease. NRF2 (Nuclear Factor-Erythroid 2 Like 2) is a transcription factor that orchestrates the cellular response to oxidative stress. The regulation of NRF2 signalling has been shown to be a promising strategy to modulate the progression of the neurodegeneration associated to Parkinson’s disease. The NRF2 pathway has been shown to be affected in patients with this disease, and activation of NRF2 has neuroprotective effects in preclinical models, demonstrating the therapeutic potential of this pathway. In this review, we highlight recent advances regarding the regulation of NRF2, including the effect of Angiotensin II as an endogenous signalling molecule able to regulate ROS production and oxidative stress in dopaminergic neurons. The genes regulated and the downstream effects of activation, with special focus on Kruppel Like Factor 9 (KLF9) transcription factor, provide clues about the mechanisms involved in the neurodegenerative process as well as future therapeutic approaches.

Keywords